Cannabinoids for major neurocognitive disorder: case report and literature review
Rev. colomb. psiquiatr; 50 (1), 2021
ABSTRACT Introduction: Major neurocognitive disorder (MNCD) affects millions of people worldwide. However, the pharmacological options for its management are limited, ineffective and frequently associated with severe adverse reactions. Case report: An 85-year-old man with history of multiple chronic ...